Here’s what you need to know:
1. Dr. Beswick studies granulocyte-colony stimulating factor, a protein which may play a role in colon tumor growth.
2. In the past, she has shown that colon and stomach tumors have more G-CSF and G-CSF receptor than normal tissues, and that blocking G-CSF in mice causes the tumors to shrink. She has also showed that, in mice, blocking G-CSF drew three kinds of immune cells to the tumor.
3. With the NIH grant, Dr. Beswick will study both how G-CSF keeps tumor cells from multiplying and how it affects different immune cells.
4. Dr. Beswick will also use these funds to test her previous findings in human tumor tissues.
5. She hopes her research will lead to the development of a new drug to treat colorectal cancer.
More articles on gastroenterology and endoscopy:
10 Things to Know About Adenoma Detection
Opportunities for small GI practices under MACRA: 4 notes
Who is Donald Trump’s gastroenterologist, Dr. Harold Bornstein?: 5 things to know
